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Abstract
In youth, ADHD is more commonly diagnosed in males than females, but higher male-to-female ratios are found in clini-
cal versus population-based samples, suggesting a sex bias in the process of receiving a clinical diagnosis of ADHD. This 
study investigated sex differences in the severity and presentation of ADHD symptoms, conduct problems, and learning 
problems in males and females with and without clinically diagnosed ADHD. We then investigated whether the predictive 
associations of these symptom domains on being diagnosed and treated for ADHD differed in males and females. Parents 
of 19,804 twins (50.64% male) from the Swedish population completed dimensional assessments of ADHD symptoms and 
co-occurring traits (conduct and learning problems) when children were aged 9 years. Children from this population sample 
were linked to Patient Register data on clinical ADHD diagnosis and medication prescriptions. At the population level, 
males had higher scores for all symptom domains (inattention, hyperactivity/impulsivity, conduct, and learning problems) 
compared to females, but similar severity was seen in clinically diagnosed males and females. Symptom severity for all 
domains increased the likelihood of receiving an ADHD diagnosis in both males and females. Prediction analyses revealed 
significant sex-by-symptom interactions on diagnostic and treatment status for hyperactivity/impulsivity and conduct prob-
lems. In females, these behaviours were stronger predictors of clinical diagnosis (hyperactivity/impulsivity: OR 1.08, 95% CI 
1.01, 1.15; conduct: OR 1.43, 95% CI 1.09, 1.87), and prescription of pharmacological treatment (hyperactivity/impulsivity: 
OR 1.24, 95% CI 1.02, 1.50; conduct: OR 2.20, 95% CI 1.05, 4.63). Females with ADHD may be more easily missed in the 
ADHD diagnostic process and less likely to be prescribed medication unless they have prominent externalising problems.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a neu-
rodevelopmental disorder characterised by age-inappropriate 
and maladaptive levels of inattention and/or hyperactivity/
impulsivity. In children and adolescents, ADHD is more 
commonly diagnosed in males, with the sex ratio ranging 
from 2:1 to 10:1 [1–5]. However, sex ratios appear to be 
dependent on the type of sample, with higher male-to-female 
ratios found in clinical versus population-based samples. 
Furthermore, the male-to-female ratio is smaller in adult 
clinic samples than in childhood and adolescent samples 
[6]. This suggests that, in youth, ADHD affects a greater 
proportion of females than reflected in clinical practice and 
that differences exist in the diagnostic process for males and 
females with ADHD symptoms [7, 8].
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The findings relating to sex differences in ADHD are 
variable and sometimes contradictory, partly due to differ-
ences in sample characteristics. Meta-analyses tend to show 
less severe symptoms in females versus males with ADHD 
identified from non-referred, community populations, but 
similar levels in clinically ascertained samples—with the 
exception of inattention for which females had higher rat-
ings in the more recent meta-analysis [5, 9]. Several other 
studies have also not found support for sex differences for 
ADHD symptoms and co-occurring problems in clinical 
and referred samples [1, 10]. While important information 
has been gained from both population-based and clinical 
samples of children with ADHD, the approach of investigat-
ing sex differences in either a population-based or clinical 
sample means that it is not clear what factors are specifically 
leading to the clinical diagnosis of children with ADHD 
from the population, and if these differ as a function of sex.
Sex differences in the phenotypic expression of ADHD 
are often proposed as an explanation for the greater rates of 
ADHD diagnosis in males. A common hypothesis is that 
females with ADHD are more likely to present with predom-
inantly inattentive symptoms, and less hyperactive/impulsive 
or conduct problems than boys, and are thus perceived as 
less problematic [4, 7, 11]. Therefore, females with ADHD 
problems that manifest as predominantly inattentive symp-
toms and lower levels of disruptive behaviours may be less 
likely to receive a diagnosis of ADHD [5].
Studies also show sex differences in the pattern of ADHD 
treatment, with males being more likely to receive ADHD 
medication than females [12, 13]. However, the underlying 
reasons for the observed sex differences in treatment remain 
to be investigated. Different pharmacological treatment 
rates in males and females could also be due to a different 
manifestation of the disorder. It is important to understand 
whether certain symptom manifestations have greater influ-
ence on being prescribed pharmacological treatment, and 
the possibility that females with ADHD are undertreated is 
an important public health concern [8].
Another consideration in the diagnostic and treatment 
process of individuals with ADHD is the presence of co-
occurring learning problems, since learning problems rep-
resent another leading reason for identification of children 
with ADHD. Research has demonstrated that females with 
ADHD are less likely to have learning difficulties or mani-
fest problems at school compared to males [14, 15], which 
could also lead to lower identification of ADHD in females. 
Sex differences in learning problems related to ADHD, and 
their impact on the diagnostic and treatment process, are not 
well investigated.
This study investigated sex differences in ADHD using 
a large population-based sample [The Child and Adoles-
cent Twin Study in Sweden (CATSS)] linked to Swedish 
National Patient Register data on clinical ADHD diagnoses 
and prescribed ADHD medications. Thus, enabling investi-
gation of a population-based and clinical sample for which 
there is not an ascertainment bias and overcoming important 
limitations of studies reliant on one type of sample alone. 
We first described the severity of ADHD symptoms, con-
duct, and learning problems in males and females with and 
without clinically diagnosed ADHD, followed by examina-
tion of the ADHD symptom presentation. We then inves-
tigated whether the predictive associations of inattention, 
hyperactivity/impulsivity, conduct problems, and learning 
problems on being diagnosed and treated for ADHD dif-
fered in males and females. It was hypothesised that (1) at 
the population level, males would show greater symptom 
severity than females, but at the clinical level similar sever-
ity would be observed, with the exception of inattention for 
which levels may be higher in females as suggested by meta-
analysis, (2) hyperactivity/impulsivity and conduct problems 
would be a stronger predictor of diagnosis in females than in 
males and inattention a weaker predictor, and (3) in children 
with a clinical diagnosis of ADHD, hyperactivity/impulsiv-
ity and conduct problems would be a stronger predictor of 
medication status in females than males.
It is important to increase our understanding of sex effects 
in ADHD and whether certain symptoms are more predic-
tive of clinical diagnosis and pharmacological treatment 
(including whether sex differences in such predictors exist), 
as it can lead to improved identification of females with the 
disorder. Furthermore, it may point towards certain biases 
in the diagnostic and treatment process which has implica-
tions for clinical practice and can inform our understanding 
of the way that clinicians recognise ADHD symptoms, and 
potentially apply the diagnostic criteria.
Methods
Sample
Participants were from The Child and Adolescent Twin 
Study in Sweden (CATSS) [16], an ongoing prospective lon-
gitudinal cohort twin study that targets all twins in Sweden 
born since 1992. A telephone interview is conducted with 
parents of all twins, no more than 1 month before or after 
their 9th or 12th birthdays (CATSS-9/12; baseline). For the 
present study, data from 19,804 CATSS children assessed at 
age 9 years were available for analyses (50.64% males). The 
CATSS-9/12 study has ethical approval from the Karolinska 
Institute Ethical Review Board and participants are protected 
by the informed consent process.
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Measures
ADHD symptoms and co-occurring behavioural traits 
The Autism-Tics, AD/HD and other Comorbidities Inven-
tory (A-TAC) was administered to parents of twins over 
the telephone, and questions were asked from a lifetime 
perspective. The A-TAC is a broad screening instrument 
that encompasses multiple neurodevelopmental disorders. 
Two modules of the A-TAC are used to assess ADHD (one 
assessing inattention [9 items] and one assessing hyperac-
tivity/impulsivity [10 items]), consisting of a total of 19 
items that correspond closely to DSM-5 diagnostic crite-
ria for ADHD [17]. Questions are answered on a 3-point 
scale: ‘no’ (scored as 0), ‘yes, to some extent’ (scored as 
0.5), and ‘yes’ (scored as 1). Thus, the maximum score 
that can be obtained is 19. These questions were identified 
to achieve the optimal sensitivity, specificity, and predic-
tive value for clinical ADHD diagnoses in validation stud-
ies, with high internal consistency [18–21].
Using the A-TAC ADHD items, it is possible to cat-
egorise individuals based on DSM-5 symptom criteria for 
the three ADHD presentations: the predominately inat-
tentive presentation, based on the presence of six or more 
symptoms of inattention; the predominantly hyperactive/
impulsive presentation, based on the presence of six or 
more symptoms of hyperactivity/impulsivity (using nine 
of the ten A-TAC items); and the combined presentation, 
based on six or more symptoms of both inattention and 
hyperactivity/impulsivity. From the three-point scale 
described above, we dichotomised responses for each item 
into ‘symptom present’ (‘yes’ and ‘yes to some extent’ 
were collapsed into one category) and ‘symptom absent’ to 
enable categorisation of participants into one of the three 
ADHD presentations.
The A-TAC also includes questions that target other 
well-described clinical features of psychiatric disorders, 
such as conduct problems (five items relating to lying, 
cheating, stealing, being cruel, or starting fights) and 
learning difficulties (three items relating to reading and 
maths skills and slow learning), also scored on a three-
point scale as above. Thus, whilst looking specifically at 
one disorder, co-occurring problems can also be exam-
ined. Of note, although the A-TAC also includes questions 
on anxiety and mood, we were unable to examine these 
variables due to a reduced number of CATSS participants 
completing these questions.
Socio-Economic Status (SES) Maternal education from 
the Swedish Register of Education was used as an indica-
tor of socio-economic status. A categorical variable was 
created (low = primary and secondary education, ≤ 9 years; 
medium = upper secondary education, 10–12  years; 
high = post-secondary education, > 12 years).
Population‑based registers
Unique personal identifier numbers enable data from par-
ticipants in the CATSS sample to be accurately linked with 
information from National population-based registers up 
until December 2013. Thus, it was possible to determine 
whether participants in CATSS had been referred to a spe-
cialist clinic and diagnosed with ADHD, and if they were 
prescribed ADHD medication. Registry data were also used 
to identify 273 participants in CATSS who had emigrated 
(obtained from The Migration Register) or died (obtained 
from The Cause of Death Register) after their participation 
in the study; these individuals were excluded from analyses.
The National Patient Register (NPR) The NPR contains 
information about all psychiatric inpatient (from 1987) 
and outpatient (from 2001) care in Sweden, from both pri-
vate and public caregivers (primary care is not currently 
included). Clinical ADHD diagnoses are based on the Inter-
national Classification of Diseases (ICD), code F90 [22], 
but most clinicians base their clinical assessment on DSM 
criteria for ADHD and recode to ICD. Participants were 
identified as having a diagnosis of ADHD from the NPR if 
they had at least one record of inpatient or outpatient care 
for ADHD from 2001 to 2013.
Prescribed Drug Register (PDR) The PDR contains data 
for all dispensed drug prescriptions to the entire Swedish 
population since July 2005. Information on the indication for 
the prescription is not recorded; however, ADHD is a group 
that can be identified as treatment is characterised by a few 
drugs exclusively used for this disorder (methylphenidate 
hydrochloride, atomoxetine, amphetamine sulfate, or dex-
troamphetamine sulfate). Participants treated with ADHD 
medication were identified if they had at least one prescrip-
tion from 2005 to 2013.
Statistical analysis
Descriptive statistics are presented to describe the sever-
ity and presentation of ADHD symptoms and co-occurring 
behaviours in males and females with and without clinically 
diagnosed ADHD. Sex differences in parent-rated ADHD 
symptom scores (inattention and hyperactivity/impulsivity) 
and co-occurring conduct and learning problems scores were 
tested using linear regression models (hypotheses 1), and 
sex differences in ADHD medication status was tested using 
logistic regression.
To assess whether the predictive associations of inat-
tention, hyperactivity/impulsivity, conduct problems, and 
learning problems with clinical diagnoses differed in males 
and females, we used a series of logistic regression models 
(hypotheses 2). The models were conducted separately for 
each symptom domain (inattention, hyperactivity/impul-
sivity, conduct problems, and learning problems) using 
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the continuous score, and stratified by sex. We also applied 
logistic regression models with males and females included 
in one model to investigate sex-by-symptom interactions on 
diagnostic status (again, separate models were run for each 
symptom domain using the continuous score).
Next, we used a series of logistic regression models to 
examine sex differences in the associations between these 
symptom domains and ADHD medication status in children 
with clinically diagnosed ADHD (hypotheses 3). The mod-
els were conducted separately for each symptom domain 
using the continuous score and stratified by sex. We also 
investigated sex-by-symptom interactions on treatment 
status.
All regression models were adjusted for the effects of 
year of birth and family SES. Furthermore, as the data were 
used as population data and not analysed in a twin analysis 
model, we controlled for the clustered data structure (to cor-
rect for the inclusion of two study children in each family) 
using a cluster-robust sandwich estimator (the cluster(vce) 
command in Stata [23]).
Results
Prevalence
In the CATSS sample, 3.28% (n = 650) of the children had a 
clinical diagnosis of ADHD recorded in the National Patient 
Register (NPR). Clinically diagnosed ADHD was more 
common in males (4.65%, n = 466) than in females (1.88%, 
n = 184), which corresponds to a prevalence ratio of ~ 2.5:1.
Based on DSM-5 ADHD symptom criteria using the par-
ent-reported A-TAC questionnaire, 2556 individuals (12.9%) 
from the CATSS sample met criteria for ADHD. More 
males (16.3%, n = 1635) than females (9.43%, n = 921) met 
the symptom criteria, corresponding to a prevalence ratio 
of ~ 1.8:1. Among these children, 303 (18.5%) of the males 
with elevated symptoms, and 111 (12.1%) of the females 
with elevated symptoms had an ADHD diagnosis recorded 
in the NPR.
Symptom severity
Table 1 shows mean symptom scores for children with and 
without a clinical diagnosis of ADHD in the NPR. Among 
non-diagnosed children, females had significantly lower 
scores compared to males for total ADHD, inattention, 
hyperactivity/impulsivity, conduct problems, and learn-
ing problems (p values < 0.001). In contrast, among chil-
dren with clinically diagnosed ADHD, males and females 
showed similar severity across the symptom domains, except 
for significantly higher inattention scores in males (p = 0.03, Ta
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d = 0.21). Females and males with a clinical diagnosis were 
equally likely to be prescribed ADHD medication.
ADHD presentations
Among all children from the CATSS sample meeting 
DSM-5 symptom criteria for ADHD as identified with the 
parent-reported A-TAC questionnaire, the inattentive presen-
tation was most common (53.7%), followed by the combined 
(26.8%) and hyperactive/impulsive (19.5%) presentations 
(Table 2). A significantly greater percentage of females met 
symptom criteria for the inattentive presentation category 
compared to males (χ2(1) = 11.27, p = 0.002, d = 0.11), and 
a significantly greater percentage of males met symptom 
criteria for the combined presentation category compared to 
females (χ2(1) = 17.39, p < 0.001, d = 0.15). There was a sim-
ilar percentage of males and females meeting symptom crite-
ria for the hyperactive/impulsive presentation (χ2(1) = 0.19, 
p = 1.0, d = 0.08).
Looking exclusively among the children clinically diag-
nosed with ADHD in the NPR, the combined presentation 
was most common (55.3%), followed by the inattentive 
(36.7%) and hyperactive/impulsive (8.0%) presentations 
(Table 2). Among these cases, there were no statistically 
significant differences between males and females in the 
ADHD presentations (Table 2).
Does the predictive value of ADHD symptoms, 
conduct problems, and learning problems on ADHD 
diagnosis and treatment differ by sex?
Using the A-TAC continuous scores, in both males and 
females, symptom severity with respect to inattention and 
hyperactivity/impulsivity increased the likelihood of receiv-
ing a clinical ADHD diagnosis (Table 3) (for example, for 
males, with each unit increase on the inattention scale the 
odds of having a clinical diagnosis of ADHD increased by 
1.67, whereas in females the odds increased by 1.73). Co-
occurring conduct and learning problems were also associ-
ated with an increased likelihood of ADHD diagnosis in 
both males and females. Odds ratios were higher across all 
predictors in females than males, although these differences 
were small and non-significant for inattention and learning 
problems. Interaction analyses revealed sex-by-symptom 
interactions for hyperactivity/impulsivity (OR 1.08, 95% CI 
1.01, 1.15, p = 0.03) and conduct problems (OR 1.43, 95% 
CI 1.09, 1.87, p = 0.01), suggesting that externalising symp-
toms of hyperactivity/impulsivity and conduct problems are 
more strongly associated with the prediction of clinically 
diagnosed ADHD in females than in males.
Symptom severity with respect to hyperactivity/impul-
sivity increased the likelihood of being prescribed ADHD 
medication in both sexes (Table 4). Inattention and conduct Ta
bl
e 
2 
 A
DH
D 
pr
es
en
tat
io
ns
 ba
se
d o
n D
SM
-5
 cr
ite
ria
 sy
m
pt
om
 co
un
ts 
m
ea
su
re
d w
ith
 pa
re
nt
-ra
ted
 A
-T
AC
, i
n t
he
 en
tir
e C
AT
SS
 po
pu
lat
io
n a
nd
 di
ag
no
se
d c
hi
ld
re
n
Bo
ld
 da
ta 
sig
ni
fy
 st
ati
sti
ca
l s
ig
ni
fic
an
ce
 of
 th
e t
es
ts
N
PR
 N
ati
on
al 
Pa
tie
nt
 R
eg
ist
er
a  In
clu
siv
e o
f c
hi
ld
re
n w
ith
 a 
cli
ni
ca
l d
iag
no
sis
b  2
36
 ch
ild
re
n (
16
3 m
ale
s) 
di
d n
ot
 m
ee
t s
ym
pt
om
 cr
ite
ria
 fo
r a
ny
 of
 th
e p
re
se
nt
ati
on
s b
as
ed
 on
 th
e A
-T
AC
 
c  C
hi
 sq
ua
re
 te
sts
 ar
e a
dj
us
ted
 fo
r m
ul
tip
le 
tes
tin
g u
sin
g B
on
fer
ro
ni
 co
rre
cti
on
Pr
es
en
tat
io
n;
 n 
(%
)
En
tir
e  p
op
ul
ati
on
a
Di
ag
no
se
d i
n t
he
  N
PR
b
Ov
er
all
M
ale
s
Fe
m
ale
s
χ
2 c
P
Co
he
n’s
 d
Ov
er
all
M
ale
s
Fe
m
ale
s
χ
2 c
P
Co
he
n’s
 d
In
att
en
tiv
e
13
72
 (5
3.7
)
83
7 (
51
.2)
53
5 (
58
.1)
11
.27
.00
2
0.1
1
15
1 (
36
.7)
10
7 (
35
.6)
44
 (3
9.6
)
0.5
6
1.0
− 
0.0
2
Hy
pe
ra
cti
ve
/im
pu
lsi
ve
49
9 (
19
.5)
31
5 (
19
.3)
18
4 (
20
.0)
0.1
9
1.0
0.0
8
33
 (8
.0)
25
 (8
.3)
8 (
7.2
)
0.1
3
1.0
0.0
5
Co
m
bi
ne
d
68
5 (
26
.8)
48
3 (
29
.5)
20
2 (
21
.9)
17
.39
<.
00
1
0.1
5
22
8 (
55
.3)
16
9 (
56
.1)
59
 (5
3.2
)
0.2
9
1.0
0.0
9
 European Child & Adolescent Psychiatry
1 3
problems were associated with an increased likelihood of 
being prescribed medication in females, but not in males. 
Interaction analyses revealed sex-by-symptom interactions 
for hyperactivity/impulsivity (OR 1.24, 95% CI 1.02, 1.50, 
p = 0.03) and conduct problems (OR 2.20, 95% CI 1.05, 
4.63, p = 0.04), suggesting that externalising symptoms of 
hyperactivity/impulsivity and conduct problems influence 
being prescribed pharmacological treatment for ADHD to 
a greater extent in females than males. Learning problems 
did not predict medication treatment in the sample overall, 
or for either males or females (Table 4).
Discussion
This large population-based study investigated the role of 
sex differences in ADHD symptoms and co-occurring con-
duct and learning problems on clinical diagnosis and phar-
macological treatment of ADHD. The main finding was 
that the predictive association of hyperactive/impulsive and 
conduct symptoms on ADHD diagnosis and treatment sta-
tus was stronger in females than in males. We also found, 
consistent with previous findings, greater ADHD symptoms 
and co-occurring conduct and learning problems in males 
than females at the population level [2, 14], more males 
than females received a clinical diagnosis of ADHD, and 
that clinically diagnosed males and females showed similar 
symptom severity [5, 15, 24, 25], except for higher inat-
tention scores in males (which is not in line with the most 
recent meta-analysis showing greater inattention in females, 
but the effect size was modest: d = 0.21).
Severity of all the symptom domains assessed increased 
the likelihood of having a clinical diagnosis of ADHD in 
both males and females. Across all domains, odds ratios 
were slightly higher for females, suggesting greater devia-
tion from their typical behaviour, and may indicate a greater 
symptom threshold requirement for referral and diagnosis 
in females. Significant sex differences were found for the 
predictive value of hyperactivity/impulsivity and conduct 
problems, with these externalising behaviours being stronger 
predictors of diagnosis in females than males. This finding 
is consistent with a previous study showing that girls with 
externalising symptoms were referred at a younger age than 
boys with similar behavioural problems [24]. One explana-
tion for this finding is that externalising symptoms are in 
greater contrast to what is perceived as normative behaviour 
Table 3  Predictive value of 
core ADHD symptoms and 
co-occurring problems on 
clinical ADHD diagnosis 
(based on the National Patient 
Register) in males and females
Bold data signify statistical significance of the tests
All models were adjusted for familial clustering, year of birth, and SES
OR Odds Ratio (95% confidence interval)
a Data were missing on some variables; all available data were used in analysis
Characteristica Males Females Interaction (sex-by-
symptom)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Inattention 1.67 (1.61, 1.74) <.001 1.73 (1.63, 1.84) <.001 1.02 (0.96, 1.10) .43
Hyperactivity/impulsivity 1.55 (1.49, 1.61) <.001 1.68 (1.58, 1.77) <.001 1.08 (1.01, 1.15) .03
Conduct problems 2.79 (2.41, 3.25) <.001 4.09 (3.20, 5.23) <.001 1.43 (1.09, 1.87) .01
Learning problems 2.53 (2.28, 2.81) <.001 2.87 (2.45, 3.35) <.001 1.11 (0.93, 1.33) .25
Table 4  Influence of core 
ADHD symptoms and 
co-occurring problems 
on prescription of ADHD 
medication (in the Prescribed 
Drug Register) in males and 
females with a clinical diagnosis 
of ADHD (in the National 
Patient Register)
Bold data signify statistical significance of the tests
All models were adjusted for familial clustering, year of birth, and SES
OR Odds Ratio (95% confidence interval)
a Data were missing on some variables; all available data were used in analysis
For mean scores of clinically diagnosed males and females stratified by medication prescription, see Sup-
plementary Table 2
Characteristica Males Females Interaction (sex-by-
symptom)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Inattention 1.08 (.98, 1.20) .12 1.22 (1.05, 1.42) .01 1.13 (0.95, 1.34) .16
Hyperactivity/impulsivity 1.12 (1.02, 1.23) .01 1.37 (1.15, 1.64) .001 1.24 (1.02, 1.50) .03
Conduct problems 1.04 (.78, 1.36) .76 2.29 (1.09, 4.82) .03 2.20 (1.05, 4.63) .04
Learning problems 1.05 (.79, 1.39) .75 0.83 (.56, 1.23) .36 0.84 (0.53, 1.31) .44
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in females [7, 24, 26]. Indeed, we found lower levels of 
hyperactivity/impulsivity and conduct problems in females 
versus males without a diagnosis of ADHD (i.e., lower base-
line levels). These results may also suggest that externalis-
ing behaviours drive referral for ADHD [7], speaking to the 
view that externalising behaviours are more likely to get 
females clinical recognition for their symptoms. Finally, our 
finding that externalising behaviours are stronger predictors 
of diagnosis in females than males suggests that females 
with ADHD may be more easily missed in the ADHD diag-
nostic process unless they have prominent externalising 
problems. This may suggest that the current diagnostic cri-
teria and/or clinical practice are somewhat biased towards 
the male presentation of ADHD, and has implications for 
clinical training related to sex role socialisation.
Both hyperactivity/impulsivity and conduct problems 
were also stronger predictors of ADHD medication status 
in females compared to males, despite clinically diagnosed 
males and females being equally as likely to be prescribed 
ADHD medication. This suggests that if females display less 
prominent externalising behavioural problems they are less 
likely to be prescribed medication, whereas males may be 
prescribed medication based on ADHD diagnostic status 
alone.
We found no difference in learning problem scores by 
sex in those with ADHD, which is in contrast to previous 
research showing more pronounced learning and school-
related problems in males with ADHD than in females [14, 
15]. Furthermore, the predictive association between learn-
ing problems and ADHD diagnosis was similar in males 
and females. However, learning problems were not asso-
ciated with being prescribed medication, suggesting that 
learning problems may not be pertinent to pharmacological 
treatment decisions for children with ADHD, and in cases 
where learning problems are particularly prominent in the 
presentation, alternative interventions may be adopted. The 
relevance of learning problems to referral, diagnosis, and 
treatment of ADHD may also differ across countries, where 
differing importance may be placed on these difficulties in 
the diagnostic process. It would be interesting to see if find-
ings regarding the impact of learning problems on diagnosis 
and treatment are replicated in other countries.
Our study found that the combined presentation was 
the most common ADHD presentation in children with a 
clinical diagnosis. In contrast, among the children meeting 
ADHD criteria based on parent-rated symptoms, the inatten-
tive presentation was the most common, which is consistent 
with some previous research [3, 7, 14, 27, 28], but not all 
studies [1, 29]. This suggests that some children with pri-
marily inattentive symptoms may not get diagnosed with 
ADHD. It is possible that: (1) children with predominantly 
inattentive symptoms are referred but may receive alterna-
tive diagnoses in the absence of externalising behaviours [7, 
11]; (2) children with the inattentive presentation may be 
perceived as less impaired and their behaviour as less prob-
lematic in comparison to disruptive behavioural problems 
[30, 31]. These possibilities may be of particular relevance 
to females, since we found a greater percentage of females 
than the percentage of males presented with predominately 
inattentive symptoms at the population level. This could par-
tially explain the greater number of males than females in 
clinical samples of children with ADHD compared to non-
referred samples [14].
This study represents one of the largest samples used to 
investigate sex differences in ADHD. In addition, previous 
studies have investigated sex differences in either clinical 
or population samples; here, we uniquely bring the two 
together. This enabled investigation of a population-based 
and clinical sample for which there is not an ascertainment 
bias, overcoming limitations of studies using one type of 
sample alone. Prevalence rates in this cohort are in line with 
expectations and suggest an overall reasonable detection of 
ADHD in Sweden. The administrative prevalence of ADHD 
was 3.28%, and the symptomatic prevalence based on the 
A-TAC was substantially higher at 12.9% as impairment 
criteria and symptom pervasiveness across settings were 
not applied, consistent with previous estimates of ADHD 
classification based on symptom counts alone [3]. However, 
this rate is similar to estimates from other community studies 
that apply impairment criteria [2]. Of note, another potential 
explanation for the prevalence difference between clinically 
diagnosed ADHD and symptomatic ADHD is that males and 
females who have less pronounced levels of externalising 
behaviours and a predominantly inattentive presentation are 
less often clinically diagnosed. Among children clinically 
diagnosed with ADHD, the ratio of males to females was 
2.5:1, which is somewhat lower than previously reported 
[5, 9]. Of the entire CATSS sample, the ratio of males to 
females meeting symptomatic threshold was 1.8:1, which is 
consistent with previous findings [3]. Thus, the difference 
in ratios of males to females in the clinical and population 
sample was small, and findings of this study may not gen-
eralise to countries with lower (or higher) administrative 
prevalence rates.
Our findings should be considered in the context of some 
limitations. Our findings are telling us about diagnosis pat-
terns and do not provide information about referral pat-
terns. It is possible that a number of children are referred 
but receive alternative diagnoses or are not considered 
sufficiently impaired by symptoms to obtain a diagnosis. 
Future studies should investigate such hypotheses. We were 
also unable to confirm whether additional children from 
CATSS should have a clinical diagnosis of ADHD (i.e., 
children who are potentially ‘missed’ in the community); as 
an epidemiologic cohort, our study did not have objective 
clinician or research interviews. Furthermore, we relied on 
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parent-ratings of ADHD symptoms and co-occurring prob-
lems, which may be influenced by sex-specific biases and 
expectations [26, 32]. For example, there is some evidence 
that parents may underrate females’ ADHD symptoms 
compared to males [32]. A further limitation is that, unfor-
tunately, our main analyses did not examine co-occurring 
internalising problems due to a reduced number of CATSS 
participants completing these measures. Sex differences in 
internalising problems have been reported [9] and further 
research is needed to explore the predictive associations with 
diagnosis and treatment of ADHD. We were also unable to 
explore potential sex differences in referral to non-pharma-
cological interventions for ADHD. Finally, the study was 
carried out in a twin sample and findings may not generalise 
to singletons; for example, twins are more likely to have 
lower birth weight compared to singletons which is a risk 
factor for ADHD [33, 34]. Findings require replication in a 
non-twin sample.
These limitations notwithstanding, overall the current 
findings highlight the importance of the clinical presenta-
tion of ADHD as it can influence diagnosis and treatment 
decisions differentially in males and females, and the promi-
nence of different symptoms clearly matters. Externalising 
behavioural problems were more predictive of diagnosis and 
pharmacological treatment in females than males, perhaps 
because they contrast more with perceptions of normative 
behaviour in females. One interpretation of these findings 
is that females with ADHD may be under-identified in the 
absence of prominent externalising problems.
We hope that our findings encourage more research in this 
area to foster greater understanding of sex-specific diagnos-
tic patterns and more effective recognition, diagnosis, and 
treatment of ADHD in females in clinical, educational, and 
other settings.
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